The ETNA-VTE-KOR-TWN study: Real-world outcomes of edoxaban use in patients with venous thromboembolism in South Korea and Taiwan

Introduction: Long-term (>6 months), real-world evidence on the effectiveness and safety of edoxaban for venous thromboembolism (VTE) management including data from South Korea and Taiwan remain limited. The global ETNA-VTE programme evaluated real-world outcomes of edoxaban-treated patients. Materi...

Полное описание

Библиографические подробности

Главные авторы:	Won-Il Choi, Kuan-Ming Chiu, Hang-Jae Jang, Jung-Hyun Choi, Won-Yeon Lee, Kye-Hun Kim, Pei-Ying Pai, Wei-Tien Chang, Ching-Pei Chen, Matthew Clasen, Katharina Wenz-Poeschl, Thomas Malzer, Martin Unverdorben, Ulrike Thee, Eva-Maria Fronk
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Elsevier 2026-06-01
Серии:	Thrombosis Update
Предметы:	Anticoagulant Deep vein thrombosis South Korea Recurrence Taiwan Venous thromboembolism
Online-ссылка:	http://www.sciencedirect.com/science/article/pii/S266657272600009X
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!